Cargando…

Detection and Characterization of Circulating Tumour Cells in Multiple Myeloma

Multiple myeloma (MM) remains an incurable disease despite recent therapeutic improvements. The ability to detect and characterize MM circulating tumour cells (CTCs) in peripheral blood provides an alternative to replace or augment invasive bone marrow (BM) biopsies with a simple blood draw, providi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhang, Liangxuan, Beasley, Sharon, Prigozhina, Natalie L., Higgins, Renee, Ikeda, Shoji, Lee, Florence Y., Marrinucci, Dena, Jia, Shidong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	SAGE Publications 2016
Materias:	Original Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5548310/ https://www.ncbi.nlm.nih.gov/pubmed/28936258 http://dx.doi.org/10.5772/64124

Ejemplares similares

Detection and Characterization of Circulating Tumour Cells from Frozen Peripheral Blood Mononuclear Cells
por: Lu, David, et al.
Publicado: (2015)

Analytical Validation and Capabilities of the Epic CTC Platform: Enrichment-Free Circulating Tumour Cell Detection and Characterization
por: Werner, Shannon L., et al.
Publicado: (2015)

Circulating tumour DNA analysis in multiple myeloma
por: Mithraprabhu, Sridurga, et al.
Publicado: (2017)

Chromosomal Instability Estimation Based on Next Generation Sequencing and Single Cell Genome Wide Copy Number Variation Analysis
por: Greene, Stephanie B., et al.
Publicado: (2016)

Circulating Tumour DNA Analysis for Tumour Genome Characterisation and Monitoring Disease Burden in Extramedullary Multiple Myeloma
por: Mithraprabhu, Sridurga, et al.
Publicado: (2018)

Development of a robust flow cytometry-based pharmacodynamic assay to detect phospho-protein signals for phosphatidylinositol 3-kinase inhibitors in multiple myeloma
por: Li, Congfen, et al.
Publicado: (2013)

Longitudinal SARS-CoV-2 antibody study using the Easy Check COVID-19 IgM/IgG™ lateral flow assay
por: Higgins, Renee L., et al.
Publicado: (2021)

Circulating tumour DNA sequence analysis as an alternative to multiple myeloma bone marrow aspirates
por: Kis, Olena, et al.
Publicado: (2017)

Cytomorphology of Circulating Colorectal Tumor Cells:A Small Case Series
por: Marrinucci, Dena, et al.
Publicado: (2010)

DNA-Repair Gene Mutations Are Highly Prevalent in Circulating Tumour DNA from Multiple Myeloma Patients
por: Mithraprabhu, Sridurga, et al.
Publicado: (2019)

Circulating tumour DNA analysis predicts relapse and improves risk stratification in primary refractory multiple myeloma
por: Mithraprabhu, Sridurga, et al.
Publicado: (2023)

Circulating Tumour Cells, Cell Free DNA and Tumour-Educated Platelets as Reliable Prognostic and Management Biomarkers for the Liquid Biopsy in Multiple Myeloma
por: Allegra, Alessandro, et al.
Publicado: (2022)

PTEN loss in circulating tumour cells correlates with PTEN loss in fresh tumour tissue from castration-resistant prostate cancer patients
por: Punnoose, Elizabeth A, et al.
Publicado: (2015)

Circulating microRNAs and Their Role in Multiple Myeloma
por: Federico, Cinzia, et al.
Publicado: (2019)

Spontaneous Tumour Lysis Syndrome in a Multiple Myeloma
por: Huzmeli, Can, et al.
Publicado: (2016)

The Mutational Landscape of Circulating Tumor Cells in Multiple Myeloma
por: Mishima, Yuji, et al.
Publicado: (2017)

Circulating biosignatures in multiple myeloma and their role in multidrug resistance
por: Krishnan, S. Rajeev, et al.
Publicado: (2023)

Biological Characterization and Clinical Relevance of Circulating Tumor Cells: Opening the Pandora’s Box of Multiple Myeloma
por: Garcés, Juan-José, et al.
Publicado: (2022)

Quantification of cellular volume and sub-cellular density fluctuations: comparison of normal peripheral blood cells and circulating tumor cells identified in a breast cancer patient
por: Phillips, Kevin G., et al.
Publicado: (2012)

Year of Expanding into Circulating Biomarkers
por: Jia, Shidong, et al.
Publicado: (2015)

Utility of Circulating Cell-Free RNA Analysis for the Characterization of Global Transcriptome Profiles of Multiple Myeloma Patients
por: Chen, Maoshan, et al.
Publicado: (2019)

Circulating miRNAs as diagnostic biomarkers for multiple myeloma and monoclonal gammopathy of undetermined significance
por: Li, Jia, et al.
Publicado: (2020)

Prognostic value of circulating plasma cells in patients with multiple myeloma: A meta-analysis
por: Li, Jia, et al.
Publicado: (2017)

Detection of metastases using circulating tumour DNA in uveal melanoma
por: Beasley, Aaron B., et al.
Publicado: (2023)

Detection and Molecular Characterization of Circulating Tumour Cells: Challenges for the Clinical Setting
por: Strati, Areti, et al.
Publicado: (2023)

Identification of circulating microRNAs as diagnostic biomarkers for use in multiple myeloma
por: Jones, C I, et al.
Publicado: (2012)

Circulating resistin levels and risk of multiple myeloma in three prospective cohorts
por: Santo, Loredana, et al.
Publicado: (2017)

Circulating microRNAs Correlate with Multiple Myeloma and Skeletal Osteolytic Lesions
por: Moura, Sara Reis, et al.
Publicado: (2021)

Tumour Dissemination in Multiple Myeloma Disease Progression and Relapse: A Potential Therapeutic Target in High-Risk Myeloma
por: Zeissig, Mara N., et al.
Publicado: (2020)

Clinical Significance of Circulating Cell-Free DNA Detection in Multiple Myeloma: A Meta-Analysis
por: Ye, Xueshi, et al.
Publicado: (2022)

Comprehensive characterization of the epigenetic landscape in Multiple Myeloma
por: Alaterre, Elina, et al.
Publicado: (2022)

High Fragmentation Characterizes Tumour-Derived Circulating DNA
por: Mouliere, Florent, et al.
Publicado: (2011)

GLIPR1 expression is reduced in multiple myeloma but is not a tumour suppressor in mice
por: Friend, Natasha, et al.
Publicado: (2020)

Epigenetic Crosstalk between Malignant Plasma Cells and the Tumour Microenvironment in Multiple Myeloma
por: Allegra, Alessandro, et al.
Publicado: (2022)

Impact of hypoxia on the pathogenesis and therapy resistance in multiple myeloma
por: Ikeda, Sho, et al.
Publicado: (2021)

Lipid metabolic vulnerabilities of multiple myeloma
por: Torcasio, Roberta, et al.
Publicado: (2023)

Monitoring multiple myeloma by next-generation sequencing of V(D)J rearrangements from circulating myeloma cells and cell-free myeloma DNA
por: Oberle, Anna, et al.
Publicado: (2017)

Circulating tumour DNA — looking beyond the blood
por: Tivey, Ann, et al.
Publicado: (2022)

Identification of mutation patterns and circulating tumour DNA-derived prognostic markers in advanced breast cancer patients
por: Liao, Hao, et al.
Publicado: (2022)

Circulating miRNA markers show promise as new prognosticators for multiple myeloma
por: Rocci, A, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_lprf536fjatetiinl29upkmotq